Group items tagged

An extensive research of the primary battery and cell markets in the world along with insights into the market size for primary batteries and cells indicate strong growth potentials and assists marketers in formulating strategic business decisions. Major product segments include air-zinc primary batteries and cells, lithium primary batteries and cells, manganese dioxide primary batteries and cells, mercuric oxide primary batteries and cells, silver oxide primary batteries and cells, parts of primary batteries and cells.

An in-depth analysis of the diverse types of therapeutics under development for T-Cell Lymphomas and identification of emerging players with potentially strong product portfolio assists marketers design effective counter-strategies to gain competitive advantage. Latest updates provide insights into the most attractive projects with emerging opportunities to enhance and expand business potential and scope.

Unmet needs in hematologic malignancies calls for companies focusing on PI3Ks and BTK inhibitors to offer better treatment options. Around USD 10 bn has already been invested in licensing and acquisition of PI3K and other kinase inhibitors since the last five years. Targeting kinases have been on the agenda of most drug developers as they hold the key path to signaling, development and growth of the cell. Large global pharma are constantly on the hunt for drugs with label expansion potential, longevity and blockbuster potential.